Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is an international, multicenter, parallel-group, randomized, double-blind, placebo-controlled trial in patients who have been stabilized during hospitalization for acute heart failure, evaluating the effect of in-hospital initiation of dapagliflozin versus placebo on the clinical outcome of cardiovascular death or worsening heart failure.
Epistemonikos ID: 53be0c5dccd9353c0401477a885c7baadb9ed66f
First added on: May 07, 2024